Inj Glycopegylated Recombinant Extended 124777415

The has published a tender for "Inj. Glycopegylated Recombinant Extended Factor VIII 500 IU,Inj. Anti Haemophilic - Each vial to contain Anti Hemophilic IX- 600 IU,Carboxy methylcellusose 1percent w-v eye drop 5ml,Gatifloxacin 0.3percent w-v Prednisolone acetate 1percent eye drop 5ml,Inj. Tocilizumab 200mg per 10 ml,Inj. Bevacizumab 25mg per ml, 4ml,Glucose Powder 75GM,Environize Anolyte Disinfectant, Vital Oxide Disinfectant, or Ultra-Lyte Disinfectant Fogger Solution Type,syp. Multivitamin, Multi Minaral and AntiOxidant Suspension Bevon type,syp. Oseltamivir Phosphate 12mg per ml,2-Propanol,1-Propanol mecetronium ethyl sulphate solution hygeienic hand disinfectant Sterillium 500 ml,Cap. Omeprazole 20 mg,Clobetesol Propionate ointment 0.05percent w-w,Cough Expectorant Diphenhydramine hydrochloride plus Ammonium Chloride plus Sodium Citrate plus Menthol 100 ml,Dextrose IV 10 percent 500 ml Bottle,Dextrose IV 25 percent 100 ml,Dextrose IV 5 percent 500 ml Bottle,Dextrose with Normal Saline IV 0.45percent 500 ml Bottle,Dextrose with Normal Sa" on the 28 Jul 2025. This tender belongs to Drugs for Eye Ear Nose Skin category. The vendors interested in this tender and related Drugs for Eye Ear Nose Skin tenders can obtain further details by exploring Tendersniper web portal. Tendersniper sends regular tender alerts by email specifically addressing the user requirements (i.e., keywords, location and value range). Government business is a growing area of opportunity. The businesses are encouraged to actively monitor tender opportunities and participate in them to grow their business.